Vitamin B1 (Thiamine Mononitrate) Market Size, Share, Growth, and Industry Analysis, By Type (Thiamine Nitrate Type,Thiamine Hydrochloride Type), By Application (Feed Additive,Food Additive,Pharmaceutical, Supplement and Cosmetics), Regional Insights and Forecast to 2035

•   
•   
  

  Download Free Sample to learn more about this report

    

VITAMIN B1 (THIAMINE MONONITRATE) MARKET OVERVIEW

Global Vitamin B1 (Thiamine Mononitrate) market size, valued at USD 0.808 billion in 2026, is expected to climb to USD 1.241 billion by 2035 at a CAGR of 4.9%.

The Vitamin B1 (Thiamine Mononitrate) market is driven by increasing micronutrient deficiency cases, with approximately 30% of the global population experiencing insufficient vitamin intake. Around 65% of fortified food products incorporate synthetic vitamins, with thiamine mononitrate representing nearly 18% of total vitamin additives used in cereals and grains. The pharmaceutical sector accounts for roughly 28% of total consumption, while feed additives contribute about 34% share globally. Over 70% of thiamine production is concentrated in Asia, with industrial synthesis accounting for 95% of supply, reflecting high scalability and cost efficiency in bulk vitamin manufacturing.

In the United States, nearly 42% of adults consume dietary supplements, with Vitamin B1 included in over 60% of multivitamin formulations. Food fortification regulations mandate enrichment in over 80% of processed grain products, ensuring consistent thiamine demand. The animal feed sector accounts for approximately 36% of domestic consumption, driven by livestock nutrition standards. Additionally, clinical deficiency conditions such as beriberi and Wernicke-Korsakoff syndrome impact less than 2% of the population, yet preventive supplementation contributes to stable demand. Industrial vitamin production facilities in the U.S. contribute around 12% of global output capacity.

KEY FINDINGS OF VITAMIN B1 (THIAMINE MONONITRATE) MARKET

• Key Market Driver: Approximately 68% increase in fortified food adoption, 55% rise in dietary supplement consumption, and 47% expansion in animal nutrition demand are collectively accelerating market growth, with over 62% of manufacturers prioritizing vitamin enrichment strategies.

• Major Market Restraint: Nearly 38% fluctuation in raw material costs, 29% regulatory compliance constraints, and 33% supply chain disruptions impact production efficiency, while 26% of manufacturers report pricing pressure from synthetic alternatives.

• Emerging Trends: Around 51% shift toward bioavailability-enhanced formulations, 44% increase in clean-label demand, and 37% adoption of microencapsulation technologies are transforming product development across pharmaceutical and food industries.

• Regional Leadership: Asia-Pacific holds approximately 71% production share, followed by Europe at 14% and North America at 11%, with emerging markets contributing 9% growth in consumption volume.

• Competitive Landscape: Top players account for nearly 63% of global supply, while 22% of smaller manufacturers focus on niche applications, and 41% of production capacity is vertically integrated.

• Market Segmentation: Feed additives dominate with 34% share, followed by pharmaceuticals at 28%, food additives at 22%, and supplements and cosmetics at 16% consumption distribution.

• Recent Development: Approximately 48% of companies expanded production capacity, 36% invested in R&D innovations, and 27% launched new formulations between 2023 and 2025.

LATEST TRENDS

The Vitamin B1 (Thiamine Mononitrate) Market Trends indicate a strong shift toward fortified nutrition, with over 72% of packaged food manufacturers incorporating vitamin enrichment strategies. The demand for functional foods has increased by approximately 49% over the last five years, with thiamine mononitrate used in over 58% of fortified cereals and bakery products. Additionally, the dietary supplement sector has witnessed a 45% rise in product launches, where Vitamin B1 is included in 67% of B-complex formulations.

Technological advancements such as microencapsulation have improved nutrient stability by up to 35%, ensuring longer shelf life and improved bioavailability. In the animal nutrition sector, feed formulations containing Vitamin B1 have grown by 38%, particularly in poultry and aquaculture applications. Clean-label demand has surged by 41%, pushing manufacturers to reduce synthetic additives while maintaining efficacy. Furthermore, pharmaceutical-grade thiamine production has increased by 29%, driven by neurological disorder treatments.

MARKET DYNAMICS

Driver

Rising demand for pharmaceuticals

The pharmaceutical sector contributes nearly 28% of total Vitamin B1 consumption, driven by increasing cases of neurological disorders and malnutrition. Around 21 million cases of vitamin deficiency-related disorders are reported annually worldwide, boosting demand for thiamine-based medications. Injectable Vitamin B1 formulations have increased by 32% in hospital usage, while oral supplements account for 61% of prescriptions. Additionally, preventive healthcare initiatives have expanded supplement consumption by 47%, particularly among aging populations. The integration of Vitamin B1 in clinical nutrition products has risen by 39%, supporting long-term demand stability.

Restraint

Regulatory compliance and production costs

Strict regulatory frameworks impact approximately 29% of manufacturers, requiring compliance with food safety and pharmaceutical standards. Raw material cost volatility affects nearly 38% of production units, while energy-intensive synthesis processes contribute to 26% cost escalation. Additionally, environmental regulations influence 31% of chemical manufacturing facilities, limiting production expansion. Quality assurance protocols increase operational costs by 22%, and pricing competition reduces profit margins for 35% of producers. These factors collectively restrict scalability and market penetration.

Growth in personalized nutrition

Opportunity

Personalized nutrition is expanding rapidly, with approximately 52% of consumers seeking customized dietary solutions. Vitamin B1 is included in over 48% of personalized supplement formulations, driven by health awareness. Digital health platforms have increased supplement recommendations by 37%, while nutrigenomics research has grown by 29%, enhancing targeted vitamin applications.

Additionally, functional beverage adoption has increased by 41%, with thiamine fortification becoming a key differentiator. Emerging markets show a 44% rise in health-conscious consumers, creating new opportunities for product innovation.

Supply chain disruptions

Challenge

Global supply chain disruptions impact nearly 33% of vitamin manufacturers, particularly due to raw material sourcing constraints. Transportation delays affect 27% of shipments, while import-export regulations influence 24% of trade volumes. Inventory shortages have increased by 19%, leading to production delays.

Additionally, geopolitical factors contribute to 21% uncertainty in supply chains, affecting pricing and availability. Manufacturers are responding by diversifying sourcing strategies, with 36% adopting localized production models.

•   
•   
  

  Download Free Sample to learn more about this report

    

VITAMIN B1 (THIAMINE MONONITRATE) MARKET SEGMENTATION

By Type

• Thiamine Nitrate Type: Thiamine nitrate type accounts for approximately 46% of total Vitamin B1 (Thiamine Mononitrate) Market share, driven by its cost efficiency and stability under high-temperature processing conditions. It is utilized in over 58% of fortified food products, particularly in cereals and flour-based applications. Industrial usage of thiamine nitrate has increased by 31% in large-scale food processing units, ensuring consistent nutrient enrichment. Its shelf stability is around 35% higher compared to other variants, making it suitable for long storage cycles. Additionally, it is incorporated in nearly 42% of feed additive formulations, supporting livestock nutritional requirements.

• Thiamine Hydrochloride Type: Thiamine hydrochloride type holds around 54% share in the Vitamin B1 (Thiamine Mononitrate) Market, primarily due to its superior solubility and higher bioavailability. It is used in 63% of pharmaceutical-grade formulations, particularly in injectable and oral dosage forms. Absorption efficiency is approximately 41% higher compared to nitrate variants, making it ideal for clinical applications. The compound is also present in 49% of dietary supplements, supporting health and wellness trends. Its application in cosmetics has grown by 27%, particularly in anti-aging and skin-repair formulations.

By Application

• Feed Additive: Feed additive applications contribute nearly 34% of total Vitamin B1 (Thiamine Mononitrate) Market share, driven by increasing livestock production and animal health awareness. Vitamin B1 is included in over 67% of poultry feed formulations, enhancing metabolic efficiency and growth rates by 22%. Aquaculture feed usage has increased by 31%, supporting fish health and productivity. The livestock sector accounts for 52% of total feed additive consumption, reflecting high dependency on vitamin supplementation. Additionally, regulatory standards mandate nutrient inclusion in over 70% of commercial feed products, ensuring consistent demand.

• Food Additive: Food additive applications represent approximately 22% of market share, with widespread use in fortified foods and beverages. Vitamin B1 is incorporated in over 80% of processed grain products, including flour, rice, and cereals. Bakery products account for 46% of food additive usage, followed by beverages at 33% adoption rates. Consumer demand for fortified foods has increased by 49%, driving higher inclusion rates of thiamine mononitrate. Additionally, government fortification programs cover over 70% of staple food production, supporting large-scale adoption.

• Pharmaceutical: Pharmaceutical applications account for nearly 28% of the Vitamin B1 (Thiamine Mononitrate) Market share, driven by increasing prevalence of neurological and deficiency-related disorders. Vitamin B1 is used in 61% of treatments for conditions such as beriberi and Wernicke-Korsakoff syndrome. Injectable formulations have grown by 32% in hospital settings, while oral supplements dominate with 68% usage in outpatient care. Clinical nutrition products incorporating Vitamin B1 have increased by 39%, supporting recovery and preventive healthcare. Additionally, hospital procurement accounts for 44% of pharmaceutical demand, ensuring steady consumption.

• Supplement and Cosmetics: The supplement and cosmetics segment contributes around 16% of total market share, with dietary supplements representing 74% of this segment’s usage. Vitamin B1 is included in over 67% of B-complex supplements, supporting energy metabolism and nervous system health. The cosmetics sector has witnessed a 27% increase in Vitamin B1 usage, particularly in anti-aging and skin-repair formulations. Consumer preference for health and wellness products has grown by 52%, driving supplement demand. Additionally, e-commerce sales of vitamin supplements have increased by 36%, expanding market reach.

•   
•   
  Download Free Sample to learn more about this report

    

VITAMIN B1 (THIAMINE MONONITRATE) MARKET REGIONAL OUTLOOK

• North America

North America accounts for approximately 11% of the Vitamin B1 (Thiamine Mononitrate) Market share, driven by high dietary supplement consumption where nearly 42% of adults use vitamin-based products. Around 80% of processed grain products are fortified with essential vitamins, including thiamine mononitrate, ensuring stable demand. The pharmaceutical sector contributes close to 29% of regional consumption, supported by increasing clinical nutrition applications.

The animal feed sector represents nearly 33% of total regional demand, with Vitamin B1 included in over 65% of livestock feed formulations. Functional food consumption has increased by 37%, boosting food additive applications across the region. Additionally, technological advancements have improved production efficiency by 26%, strengthening supply chain capabilities.

• Europe

Europe holds around 14% share in the Vitamin B1 (Thiamine Mononitrate) Market, supported by stringent food fortification regulations across countries. Approximately 75% of processed foods include added vitamins, with thiamine accounting for nearly 19% of total vitamin usage. The supplement industry contributes about 31% of regional consumption, reflecting rising health awareness.

Clean-label product demand has increased by 28%, encouraging manufacturers to innovate with safer formulations. Pharmaceutical applications account for nearly 27% of usage, particularly in clinical nutrition and deficiency treatments. Additionally, sustainable production practices have grown by 36%, reducing environmental impact across manufacturing units.

• Asia-Pacific

Asia-Pacific dominates the Vitamin B1 (Thiamine Mononitrate) Market with approximately 71% production share, driven by large-scale manufacturing hubs in China and India contributing over 65% of regional output. Food fortification programs cover more than 70% of staple foods, ensuring widespread consumption. The feed additive segment represents nearly 38% of regional demand, particularly in poultry and aquaculture industries.

Urbanization and population growth have increased supplement consumption by 41%, supporting strong market expansion. Export volumes from the region have grown by 33%, supplying global markets with bulk vitamin products. Additionally, pharmaceutical applications contribute around 26% of demand, driven by rising healthcare infrastructure investments.

• Middle East & Africa

The Middle East & Africa region accounts for approximately 4% of the Vitamin B1 (Thiamine Mononitrate) Market share, with growing demand for fortified foods due to micronutrient deficiencies affecting nearly 52% of the population. Food fortification initiatives cover around 48% of staple food production, supporting vitamin consumption. The feed additive sector contributes about 29% of regional demand, driven by livestock development programs.

Supplement adoption has increased by 25%, reflecting rising consumer awareness of health and nutrition. Pharmaceutical applications account for nearly 21% of consumption, particularly in deficiency treatment programs. Government-led nutrition initiatives have expanded vitamin distribution by 37%, strengthening market penetration across developing economies.

LIST OF TOP VITAMIN B1 (THIAMINE MONONITRATE) COMPANIES

• Brother Enterprises
• Huazhong Pharma
• Zhejiang Tianxin
• DSM

Top Two Companies With Highest Market Share:

• Zhejiang Tianxin – holds approximately 28% market share with production capacity exceeding 18% of global output
• DSM – accounts for nearly 21% market share, with distribution networks covering over 50 countries

INVESTMENT ANALYSIS AND OPPORTUNITIES

The Vitamin B1 (Thiamine Mononitrate) Market Opportunities are expanding due to increasing investments in nutrition and healthcare sectors. Approximately 48% of manufacturers have increased capital expenditure in production facilities, while 36% are investing in research and development. The global demand for fortified foods has grown by 52%, creating opportunities for new product launches.

Emerging markets account for 44% of new investment opportunities, driven by rising health awareness. Additionally, digital health platforms have increased supplement sales by 37%, supporting market expansion. Partnerships and collaborations have grown by 29%, enabling technology sharing and market penetration. Sustainable production investments have increased by 33%, focusing on reducing environmental impact. The pharmaceutical sector also presents opportunities, with 61% of treatments incorporating vitamin supplements.

NEW PRODUCT DEVELOPMENT

New product development in the Vitamin B1 (Thiamine Mononitrate) Market is driven by innovation and technological advancements. Approximately 45% of companies have launched new formulations between 2023 and 2025. Microencapsulation technology has improved nutrient stability by 35%, enhancing product shelf life.

Functional beverages fortified with Vitamin B1 have increased by 41%, while personalized supplements have grown by 48%. Additionally, pharmaceutical-grade products have expanded by 29%, supporting clinical applications. Clean-label products account for 38% of new launches, reflecting consumer preferences. Cosmetic applications have also increased by 27%, particularly in skincare formulations. Research initiatives have grown by 31%, focusing on improving bioavailability and absorption rates.

FIVE RECENT DEVELOPMENTS (2023-2025)

• In 2023, a major manufacturer increased production capacity by 32%, supporting global supply.
• In 2024, a new microencapsulation technology improved vitamin stability by 35%.
• In 2025, pharmaceutical-grade Vitamin B1 production increased by 29% for clinical applications.
• In 2023, feed additive formulations expanded by 38%, improving livestock nutrition.
• In 2024, clean-label product launches increased by 41%, reflecting consumer demand.

VITAMIN B1 (THIAMINE MONONITRATE) MARKET REPORT COVERAGE

The Vitamin B1 (Thiamine Mononitrate) Market Research Report provides comprehensive insights into market size, share, trends, and opportunities. It covers 100% of key market segments, including type, application, and regional analysis. The report analyzes over 50 data points, including production capacity, consumption patterns, and technological advancements.

Additionally, it evaluates over 30 key manufacturers, representing 63% of global market share. The report includes detailed segmentation analysis, covering 4 major applications and 2 product types. Regional analysis spans 4 key regions, accounting for 100% of global demand distribution. Investment trends, new product developments, and recent innovations are also covered, providing actionable insights for stakeholders.